4571 — Nano Holdings Share News
0.000.00%
Last trade - 00:00Brief: NanoCarrier decides to resume phase III clinical trial of NC-6004
Brief: NanoCarrier signs joint research agreement with University of Utah
Table: NanoCarrier -2016/17 parent forecast
Brief: NanoCarrier forms cooperation with TPG Biologics Inc. on joint research
Table: NanoCarrier -2016/17 parent forecast
Table: NanoCarrier -9-MTH parent results
Brief: NanoCarrier gets substance patent grant in EU
Brief: NanoCarrier commences phase I/II clinical trial for treatment of soft tissue sarcomas in U.S
Brief: NanoCarrier decides to terminate clinical trial of NC-6004
Table: NanoCarrier -6-MTH parent results
Brief: NanoCarrier cancels cancer medicine licensing and joint development contract with Kowa Company Ltd
Brief: NanoCarrier affirms safety profile and efficacy of NC-6004 in Phase Ib clinical study in US
Table: NanoCarrier -Q1 parent results
Brief: NanoCarrier says patent for nucleic acid delivery technology granted by European Patent Office
Brief: NanoCarrier says clinical trial of NC-6004
Table: NanoCarrier -2015/16 parent results
Brief: NanoCarrier receives patent recognition in Europe
Table: NanoCarrier -2015/16 parent forecast
Table: NanoCarrier -2015/16 parent forecast